BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V903. A total of 2 filers reported holding BIOCRYST PHARMACEUTICALS in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $44,000 | -21.4% | 15,500 | -21.3% | 0.00% | – |
| Q1 2016 | $56,000 | -64.6% | 19,700 | +28.8% | 0.00% | – |
| Q4 2015 | $158,000 | -98.3% | 15,300 | -98.1% | 0.00% | -100.0% |
| Q3 2015 | $9,277,000 | +2151.7% | 813,800 | +2848.6% | 0.01% | – |
| Q2 2015 | $412,000 | +368.2% | 27,600 | +181.6% | 0.00% | – |
| Q1 2015 | $88,000 | -73.9% | 9,800 | -64.6% | 0.00% | – |
| Q4 2014 | $337,000 | +6.3% | 27,700 | -14.5% | 0.00% | – |
| Q3 2014 | $317,000 | -65.8% | 32,400 | -55.4% | 0.00% | -100.0% |
| Q2 2014 | $926,000 | +20.6% | 72,600 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $768,000 | +108.7% | 72,600 | +50.0% | 0.00% | – |
| Q4 2013 | $368,000 | -5.2% | 48,400 | -9.2% | 0.00% | -100.0% |
| Q3 2013 | $388,000 | +2884.6% | 53,300 | +542.2% | 0.00% | – |
| Q2 2013 | $13,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 24,600 | $241,000 | 0.00% |
| Citadel Advisors | 32,400 | $317,000 | 0.00% |